Further studies are required to corroborate the involvement of ER stress and the UPR in the development of resistance to vemurafenib and to elucidate the role of circulating HSPA5/GRP78 in drug resistance mechanisms in BRAFV600E-mutated colon cancer. The gene discussed is HSPA5; the disease is colonic neoplasm.